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Over time eukaryotic genomes have evolved to host genes carrying multiple exons
separated by increasingly larger intronic, mostly non-protein-coding, sequences. Initially,
little attention was paid to these intronic sequences, as they were considered not to
contain regulatory information. However, advances in molecular biology, sequencing, and
computational tools uncovered that numerous segments within these genomic elements
do contribute to the regulation of gene expression. Introns are differentially removed in
a cell type-specific manner to produce a range of alternatively-spliced transcripts, and
many span tens to hundreds of kilobases. Recent work in human and fruitfly tissues
revealed that long introns are extensively processed cotranscriptionally and in a stepwise
manner, before their two flanking exons are spliced together. This process, called
“recursive splicing,” often involves non-canonical splicing elements positioned deep
within introns, and different mechanisms for its deployment have been proposed. Still,
the very existence and widespread nature of recursive splicing offers a new regulatory
layer in the transcript maturation pathway, which may also have implications in human
disease.
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INTRODUCTION
The interruption of a gene’s open reading frame by a non-protein-coding sequence, i.e., by an
intron, is an exclusive feature of eukaryotes. It is now thought that the course of evolution
has brought about such an exon-intron gene structure concomitantly with the emergence and
diversification of multicellular eukaryotes (Rogozin et al., 2012) and the need for complex gene
regulation (Jeffares et al., 2008). However, introns are not “genomic junk”; they have been shown
to confer important regulatory capacity, they typically carry cis-regulatory elements important for
both transcription and splicing (Wang and Burge, 2008; Levine, 2010), and have even been found
to be partially or fully coding (Marquez et al., 2015).
An average mammalian gene will contain 8–9 introns; >3000 human introns are longer than
50 kbp, and >1200 longer than 100 kbp (Bradnam and Korf, 2008; Shepard et al., 2009). This poses
the following problem. In long introns the three sites reactive in a splicing reaction (i.e., the 5′
splicing site, the branch-point, and the 3′ splice site; Hollander et al., 2016) will be separated by
large stretches of RNA sequence. Thus, it becomes difficult to explain how the sites required for
splicing can find one another in three-dimensional space, or how a primary transcript spanning
tens to hundreds of kbp can be protected from unspecific hydrolytic cleavage in the time it takes
an RNA polymerase to copy it as one continuous RNA (e.g., at an average speed of 3 kbp/min, >30
min are required to fully transcribe a 100 kbp-long intron; Wada et al., 2009).
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An elegant solution to this problem was proposed for
Drosophila long introns—recursive splicing (RS). According
to this, long introns are removed in a stepwise manner by
splicing at intronic sites that carry the expected acceptor and
donor splice sequences in the three gene examples studied
(consensus sequence: 5′-(Y)nNCAG|GTAAGT-3
′; the vertical
line represents the splicing junction; Burnette et al., 2005).
Similarly, a “zero-length” exon was identified between the 2nd
and 3rd exon of the rat α-tropomyosin gene (Grellscheid and
Smith, 2006), as well as “dual specificity” splicing sites in human
pre-mRNAs (Zhang et al., 2007). Still, despite computational
efforts (Shepard et al., 2009), the RS concept was not verified in
humans until 2015. A study in human primary endothelial cells
(Kelly et al., 2015), followed by two back-to-back studies across
Drosophila tissues (Duff et al., 2015) and in human brain (Sibley
et al., 2015), revealed that RS is a conserved and widespread
splicing mechanism. Nonetheless, the fruitfly and human RS-
sites differ in composition, and their molecular recognition
and processing remains unknown. Here, we discuss different
scenarios by which recursive splicing might manifest, as well
as its potential implications in gene expression regulation and
deregulation.
MODELS FOR THE PROCESSING OF
RECURSIVE SPLICING INTERMEDIATES
The idea that intronic sequences are not evolutionarily
constrained, because they do not code for proteins, pervades our
thinking; however, the conservation of parts of these non-coding
sequences between three diverse mammalian genomes (human,
whale, and seal) amounts to almost 50% in pairwise comparisons,
and to 28% amongst the three taxa (Hare and Palumbi, 2003).
This hints to the existence of underappreciated classes of intronic
regulatory elements. Recent work on recursive splicing in human
cells (Kelly et al., 2015; Sibley et al., 2015) in part confirms this by
using deep RNA sequencing and data analysis to find potential
“ratchet” RS points. A large number of RS-sites was discovered
(albeit different in the two studies, due to the different approaches
and cutoffs used), the conservation of which was higher than
that of similar, adjacent, intronic regions. These do not carry the
consensus sequence identified in Drosophila, but rather one that
contains a typical acceptor site followed by a donor sequence
that is not the expected GT/GC/GA in >60% of cases (Kelly
et al., 2015). This, of course, raises the question of how these
non-canonical sites are recognized by the splicing machinery
and processed accurately to produce a mature messenger RNA
(although RNase R-resistant lariats as a result of recursive splicing
were detected; Duff et al., 2015; Kelly et al., 2015).
One scenario could be that the vast majority of RS events
detected, especially those with non-GT sequences at donor sites,
represent “dead-end” products targeted for degradation. But, in
human primary endothelial cells, a number of evidence does not
concur with this scenario. First, the ∼2400 RS high-confidence
events recorded occur at∼15% the level of primary transcription;
second, targeted genome editing of three different RS-sites in
the 134 kbp-long intron of the SAMD4A gene showed that they
are necessary for efficient mRNA production; third, knocking-
down exosome components did not affect the levels of RS
intermediates, either GT- or non-GT-containing (Kelly et al.,
2015). Thus, splicing at RS-sites occurs at significant levels, is
widespread, and does not appear linked to exosomal degradation,
but rather to RNA maturation.
If RS intermediates lie on the productive pathway of mRNAs,
the dinucleotide immediately downstream of an RS-junction
will subsequently need to act as an efficient splicing donor. In
endothelial cells,∼45% of RS-sites encode a GN dinucleotide and
it has been shown that they can efficiently function as donors
provided strong acceptor and “splicing enhancer” sequences
also partake in that reaction (Twigg et al., 1998; Thanaraj and
Clark, 2001; Dewey et al., 2006). For the remaining 55% of
RS-sites, a combination of mechanisms might come into play.
We now know that the U1-containing snRNPs, designed to
identify the GT donor dinucleotide, are able to expand their base-
pairing repertoire via mispairing (Roca et al., 2012; Tan et al.,
2016). We have also come to find out that the human genome
encodes a large number of “variant” U1 snRNAs (Kyriakopoulou
et al., 2006; O’Reilly et al., 2013). Their expression is markedly
higher in primary, embryonic, and pluripotent cells (O’Reilly
et al., 2013; Kelly et al., 2015; Vazquez-Arango et al., 2016)
and they are able to form proper RNPs in vitro (Somarelli
et al., 2014). In endothelial cells, the repertoire of expressed
variant U1, together with the minor spliceosome (Turunen et al.,
2013), would suffice for the recognition of the vast majority
of all non-canonical RS donor dinucleotides recorded (Kelly
et al., 2015). In addition, efficient splicing has been shown
to occur independently of U1-mediated recognition (Raponi
and Baralle, 2008) or of the physical continuity of the nascent
transcript (via “exon tethering”; Dye et al., 2006). With the
aforementioned into account, we propose that long human
introns are cotranscriptionally removed by splicing at RS-sites
that may equally carry a canonical or a non-canonical donor
dinucleotide, before the two flanking exons are joined together
(Figure 1A).
Another model, proposed on the basis of data from human
brain, sees RS-sites as a means for establishing a “binary splicing
switch” (Sibley et al., 2015). However, it is worth noting here that
this study focuses specifically on RS-sites that conform to the
YAG|GT consensus, and thus investigated ∼400 such junctions.
According to this model, each RS-site may also act as an RS-
exon whereby the GT dinucleotide immediately downstream
of the splice site will compete with an alternative GT further
downstream for splicing into the canonical acceptor site at the
3′ end of the long intron. This inter-site competition determines
whether the very short RS-exon sequence will be retained as part
of the final spliced transcript or not (Figure 1B; a mechanism
similar to “intrasplicing”; Parra et al., 2008). It is suggested that
inclusion of such RS-exons will target the mature transcript
for degradation, as they encode premature termination codons
(Sibley et al., 2015). However, their inclusion (if in-frame)
will act on top of alternative splicing, and brain tissue was
shown to be uniquely prone to the inclusion of microexons into
mature mRNAs (Scheckel and Darnell, 2015), and this may not
be perfectly reconciled with this RS model. Still, despite their
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FIGURE 1 | Two models for recursive splicing processing. (A) Two consecutive exons (blue and green boxes) are separated by a long intron which contains an
RS-site with a canonical RS acceptor site and a non-canonical RS donor (YAG|NN). The GT at the 3′ end of exon 1 splices into the acceptor sequence of the RS-site,
and the non-canonical NN sequence now acts as a splice donor in the 2nd splicing step to splice the two exons together. The recognition of this non-canonical splice
site is presumably mediated by a variant U1 RNA (orange oval). (B) In a similar setup, where only RS-sites with a canonical GT donor dinucleotide are considered, the
1st splicing step occurs just as before. But, now exon 1 is spliced onto a putative cryptic or micro-exon (light blue box) that has another GT donor further
downstream. Then, competition between the two donor sites determines whether the cryptic/micro-exon will be included in the mature RNA or not. The fate of the
mRNA carrying this extra short sequence might involve degradation.
differences, both models favor “noisy splicing,” which is thought
to drive mRNA isoform diversity in human cells (Pickrell et al.,
2010).
REGULATORY AND DISEASE
IMPLICATIONS OF RECURSIVE SPLICING
The size of first introns in higher eukaryotes is such that,
on average, exceeds all other downstream introns in length
(Bradnam and Korf, 2008). This structural property of eukaryotic
genomes has been linked with programmed delays in gene
transcription cycles (Swinburne and Silver, 2008). As a result, the
preferential positioning of RS-sites in such long introns (Kelly
et al., 2015; Sibley et al., 2015) creates a novel regulatory layer
for the processing of the nascent transcripts copied from these
loci. Given that the majority of splicing in human cells occurs
cotranscriptionally (Aitken et al., 2011; Tilgner et al., 2012), it
would be reasonable to assume that the RS-junctions in one
long intron are used successively at more or less the moment
they are produced by the RNA polymerase (Figure 2A). This
is supported by the study of TNF-inducible SAMD4A; upon
induction, nascent RNA production progresses synchronously
along its first intron and intronic RNA FISH fails to return
evidence in favor of a single, long, transcript from this intron
(Wada et al., 2009; Kelly et al., 2015). Intermediate splicing
products at the 8 RS-sites in this 134-kbp intron appear and
disappear in sync with the production of nascent RNA, and the
half-life of each such RS-intermediate is ∼1/15 the time it takes
the RNA polymerase to fully transcribe this intron (Kelly et al.,
2015). This evidence, plus the “saw-tooth” patterns observed in
brain RNA-seq data (Sibley et al., 2015; see Figure 2), are in
support of the successive use of RS-sites. Nonetheless, there have
been reports of non-ordered (“nested”) use of such sites (Suzuki
et al., 2013; Gazzoli et al., 2016), whereby the RS-sites can engage
in splicing reactions decoupled from cotranscriptionality and in
which long primary transcripts survive degradation (Figure 2B).
In fact, such decoupling of RS has been proposed for yeast
splicing (Lopez and Séraphin, 2000).
Another question that arises is: Are the RS-sites in a given
long intron all used in every transcription cycle or is their
usage more stochastic? Again, studies from the SAMD4A locus
using CRISPR-Cas9 technology (Ran et al., 2013) to specifically
mutate 3 RS-sites, showed that abolishing any one RS-site results
in a 35–50% reduction in mRNA levels (Kelly et al., 2015).
Similarly, reducing RS-site usage by antisense oligonucleotides in
the zebrafish cadm2a gene led to a∼2-fold reduction in itsmRNA
levels in vivo (Sibley et al., 2015). These results (albeit based
a limited number of example loci) point to a stochastic usage
of multiple RS-sites along one intron and/or to compensatory
mechanisms that prevent a complete loss of mRNA output.
Additionally, it is necessary to investigate the connection between
RS, exon skipping, and the formation of circular RNAs from a
given gene locus, as they could all be functionally linked (Kelly
et al., 2014).
RS-sites were found to be more conserved than equivalent
intronic regions of similar composition in humans (Kelly et al.,
2015; Sibley et al., 2015), and this hinted in favor of their
functional role. As more than 90% of human genetic variation
maps outside protein-coding regions, at inter- or intragenic
sequences, and>40%maps within introns (Maurano et al., 2012),
it is attractive to hypothesize that mutations at RS-sites may
contribute to disease manifestation. Splicing defects are now
well-established contributors in various diseases (Chabot and
Shkreta, 2016), and RS, yet another layer of splicing regulation,
remains unexplored. In fact, when we intersected a list of high-
confidence RS-sites from human brain (Sibley et al., 2015)
or endothelial cells (Kelly et al., 2015) to an ensemble of
all putatively disease-causative human SNPs, they overlapped
(within the 40 preceding the RS-junction) those associated with
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FIGURE 2 | Two models for temporal progression of recursive splicing. (A) Two consecutive exons (blue and green boxes) are separated by a long intron which
contains two RS-sites with canonical RS acceptor sites and non-canonical RS donors. Typically, nascent RNA profiles (pink triangles) along such long introns display a
“saw-tooth” pattern. The GT at the 3′ end of exon 1 splices into the first RS-site, and the non-canonical GC sequence now acts as a splice donor in the 2nd splicing
step into the next RS-site, before the two exons are spliced together after the RS-sites are utilized in an ordered, co-transcriptional, manner. (B) In a similar setting
RS-sites are utilized in a non-ordered, nested, manner, which cannot be fully co-transcriptional and is also reflected on the distribution of nascent RNA. First, the
intronic segment between the two RS-sites is removed, the splicing of the RS-donor into the acceptor at exon 2 occurs, before the two exons are spliced together.
neurological (e.g., Parkinson’s disease, cognitive performance) or
circulatory disorders/traits (e.g., retinal vascular caliper, blood
pressure), respectively, more than what was expected by chance
(A. Papantonis; unpublished data). Such a potential role of
RS should be further investigated in both disease models and
in GWAS datasets, as it can—in conjunction with alternative
splicing—impact heavily on the mRNA isoform that a given cell
generates.
CONCLUSIONS AND OUTLOOK
We think that there is still much to be discovered about the
molecular basis and the regulatory implications of recursive
splicing. The presence of non-canonical splicing sequences at
RS-sites, the possibility of splice-site competition, the proposed
involvement of U1 variants, even the cotranscriptional and/or
non-sequential processing of long introns all need to be
systematically dissected. To cite just a few pertinent questions:
How widespread is recursive splicing across mammalian tissues
and developmental stages? Is it affected once cell homeostasis is
challenged, and how does this affect transcript maturation? How
are RS-sites defined, recognized, and marked epigenetically? Are
they being utilized in a stochastic or a deterministic temporal
order? Addressing these questions, amongst others, will be
important for understanding this unforeseen regulatory layer of
transcript processing in higher eukaryotes.
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